320 related articles for article (PubMed ID: 21328346)
1. Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation.
Dumitru CA; Gholaman H; Trellakis S; Bruderek K; Dominas N; Gu X; Bankfalvi A; Whiteside TL; Lang S; Brandau S
Int J Cancer; 2011 Aug; 129(4):859-69. PubMed ID: 21328346
[TBL] [Abstract][Full Text] [Related]
2. A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer.
Dumitru CA; Fechner MK; Hoffmann TK; Lang S; Brandau S
J Leukoc Biol; 2012 Apr; 91(4):591-8. PubMed ID: 22262799
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
[TBL] [Abstract][Full Text] [Related]
4. Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
Tawadros T; Alonso F; Jichlinski P; Clarke N; Calandra T; Haefliger JA; Roger T
Endocr Relat Cancer; 2013 Feb; 20(1):137-49. PubMed ID: 23207293
[TBL] [Abstract][Full Text] [Related]
5. Cell surface syndecan-1 contributes to binding and function of macrophage migration inhibitory factor (MIF) on epithelial tumor cells.
Pasqualon T; Lue H; Groening S; Pruessmeyer J; Jahr H; Denecke B; Bernhagen J; Ludwig A
Biochim Biophys Acta; 2016 Apr; 1863(4):717-26. PubMed ID: 26852939
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived MIF: a novel platelet chemokine with distinct recruitment properties.
Wirtz TH; Tillmann S; Strüßmann T; Kraemer S; Heemskerk JW; Grottke O; Gawaz M; von Hundelshausen P; Bernhagen J
Atherosclerosis; 2015 Mar; 239(1):1-10. PubMed ID: 25561410
[TBL] [Abstract][Full Text] [Related]
7. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.
Wang SS; Cen X; Liang XH; Tang YL
Oncotarget; 2017 Feb; 8(6):10650-10661. PubMed ID: 27788497
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor is involved in antineutrophil cytoplasmic antibody-mediated activation of C5a-primed neutrophils.
Hao J; Lv T; Xu L; Ran M; Wu K
BMC Immunol; 2019 Jun; 20(1):22. PubMed ID: 31248381
[TBL] [Abstract][Full Text] [Related]
10. Studying the Pro-Migratory Effects of MIF.
Hoffmann A; Zwißler LC; El Bounkari O; Bernhagen J
Methods Mol Biol; 2020; 2080():1-18. PubMed ID: 31745866
[TBL] [Abstract][Full Text] [Related]
11. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
Baron N; Deuster O; Noelker C; Stüer C; Strik H; Schaller C; Dodel R; Meyer B; Bacher M
J Neurosci Res; 2011 May; 89(5):711-7. PubMed ID: 21360573
[TBL] [Abstract][Full Text] [Related]
12. CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.
Zhang H; Ye YL; Li MX; Ye SB; Huang WR; Cai TT; He J; Peng JY; Duan TH; Cui J; Zhang XS; Zhou FJ; Wang RF; Li J
Oncogene; 2017 Apr; 36(15):2095-2104. PubMed ID: 27721403
[TBL] [Abstract][Full Text] [Related]
13. Platelets are a previously unrecognised source of MIF.
Strüßmann T; Tillmann S; Wirtz T; Bucala R; von Hundelshausen P; Bernhagen J
Thromb Haemost; 2013 Nov; 110(5):1004-13. PubMed ID: 23846621
[TBL] [Abstract][Full Text] [Related]
14. 4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas.
Varinelli L; Caccia D; Volpi CC; Caccia C; De Bortoli M; Taverna E; Gualeni AV; Leoni V; Gloghini A; Manenti G; Bongarzone I
Endocr Relat Cancer; 2015 Oct; 22(5):759-75. PubMed ID: 26206776
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
Charan M; Das S; Mishra S; Chatterjee N; Varikuti S; Kaul K; Misri S; Ahirwar DK; Satoskar AR; Ganju RK
Cell Death Dis; 2020 Sep; 11(9):774. PubMed ID: 32943608
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma.
Ren Y; Tsui HT; Poon RT; Ng IO; Li Z; Chen Y; Jiang G; Lau C; Yu WC; Bacher M; Fan ST
Int J Cancer; 2003 Oct; 107(1):22-9. PubMed ID: 12925952
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor inhibits neutrophil apoptosis by inducing cytokine release from mononuclear cells.
Schindler L; Zwissler L; Krammer C; Hendgen-Cotta U; Rassaf T; Hampton MB; Dickerhof N; Bernhagen J
J Leukoc Biol; 2021 Nov; 110(5):893-905. PubMed ID: 33565160
[TBL] [Abstract][Full Text] [Related]
18. Macrophage Migration Inhibitory Factor Limits Renal Inflammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest.
Djudjaj S; Martin IV; Buhl EM; Nothofer NJ; Leng L; Piecychna M; Floege J; Bernhagen J; Bucala R; Boor P
J Am Soc Nephrol; 2017 Dec; 28(12):3590-3604. PubMed ID: 28801314
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor reduces apoptosis in cerebral arteriovenous malformations.
Chen G; Zheng M; Shu H; Zhan S; Wang H; Zhou D; Zeng S; Tang K; Feng L
Neurosci Lett; 2012 Feb; 508(2):84-8. PubMed ID: 22206839
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.
Ohta S; Misawa A; Fukaya R; Inoue S; Kanemura Y; Okano H; Kawakami Y; Toda M
J Cell Sci; 2012 Jul; 125(Pt 13):3210-20. PubMed ID: 22454509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
